Home > BIGG > Search result

    Results: 2

    Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB and HIV-prevalence settings: 2015 update

    World Health Organization.
    In 2011 WHO conditionally recommended the use of at least 36 months of isoniazid preventive therapy (IPT) (as a proxy for lifelong or continuous treatment) for people living with HIV in high TB-prevalence and transmission settings. The evidence of the benefits and harms of 36-month IPT compared to 6-mont...
    Tuberculosis/drug therapy, AIDS-Related Opportunistic Infections/drug therapy, Isoniazid/administration & dosage, Antitubercular Agents/administration & dosage, Developing Countries
    Fulltext (primary link)     Fulltext (alternative link)    

    Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults

    World Health Organization.
    Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection. As the CD4 count declines below 200 cells/mm3, the prev...
    AIDS-Related Opportunistic Infections/drug therapy, Skin Diseases/drug therapy, Severity of Illness Index, Candidiasis, Oral/drug therapy
    Fulltext (primary link)     Fulltext (alternative link)     Fulltext (alternative link)